Edition:
United States

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

57.13USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$57.13
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
225,705
52-wk High
$65.18
52-wk Low
$10.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
FY 2016 Dec '16 0.00 -1.284
Sep '16 0.00 -0.772
Jun '16 0.00 -0.623
Mar '16 0.00 -0.647
FY 2015 Dec '15 0.00 -0.583
Sep '15 0.00 -0.569
Jun '15 0.00 -0.552
Mar '15 0.00 -0.557
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 8 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 5 0.00 0.00 0.00 --
Year Ending Dec-17 9 13.89 125.00 0.00 20.83
Year Ending Dec-18 10 32.00 220.00 0.00 22.13
Earnings (per share)
Quarter Ending Dec-17 11 -1.81 -1.47 -2.10 -1.29
Quarter Ending Mar-18 7 -1.69 -1.39 -2.03 --
Year Ending Dec-17 11 -7.36 -7.00 -7.67 -4.71
Year Ending Dec-18 11 -5.63 1.89 -8.54 -4.52
LT Growth Rate (%) 2 1.68 5.76 -2.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. -- 274.30 45.27
P/E Low - Last 5 Yrs. -- 92.17 24.24
Beta 2.74 0.83 0.91
Price to Sales (TTM) -- 113.99 5.83
Price to Book (MRQ) 5.38 21.50 5.68
Price to Tangible Book (MRQ) 5.28 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions -- 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.21 5.65
Sales - 5 Yr. Growth Rate -- 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -141.02 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago -161.35 -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate 22.82 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 5.91 5.75 3.56
LT Debt to Equity (MRQ) 0.00 14.45 13.23
Total Debt to Equity (MRQ) 0.53 16.90 19.24
Interest Coverage (TTM) -143.43 -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.05 54.80
Gross Margin - 5 Yr. Avg. -- 55.37 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -219.17 15.52
Operating Margin (TTM) -- -631.99 6.76
Operating Margin - 5 Yr. Avg. -- -236.03 11.03
Pre-Tax Margin (TTM) -- -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -236.35 11.44
Net Profit Margin (TTM) -- -600.25 3.81
Net Profit Margin - 5 Yr. Avg. -- -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,633,432 858,823,705
Net Income/Employee (TTM) -3,592,114 -1,703,997 100,224,560
Receivable Turnover (TTM) -- 25.40 6.12
Inventory Turnover (TTM) -- 2.62 3.55
Asset Turnover (TTM) 0.00 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -54.80 -9.13 11.35
Return on Assets - 5 Yr. Avg. -30.70 0.30 12.32
Return on Investment (TTM) -59.23 -11.32 14.47
Return on Investment - 5 Yr. Avg. -32.77 3.50 16.13
Return on Equity (TTM) -59.39 -35.69 16.06
Return on Equity - 5 Yr. Avg. -35.99 5.92 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -47.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 206
Total Shares Held: 27,995,949
3 Mo. Net Change: 2,795,014
# New Positions: 34
# Closed Positions: 16
# Increased Positions: 105
# Reduced Positions: 69
# Net Buyers: 36
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.